Neoadjuvant Systemic Therapy Promising for Resectable Colorectal Peritoneal Metastases 05/28/2021 Health News
First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients 06/04/2018 Health Problems
